Psychopathopharmacology 1 MSN 671 quiz 3
Access The Exact Questions for Psychopathopharmacology 1 MSN 671 quiz 3
💯 100% Pass Rate guaranteed
🗓️ Unlock for 1 Month
Rated 4.8/5 from over 1000+ reviews
- Unlimited Exact Practice Test Questions
- Trusted By 200 Million Students and Professors
What’s Included:
- Unlock 50 + Actual Exam Questions and Answers for Psychopathopharmacology 1 MSN 671 quiz 3 on monthly basis
- Well-structured questions covering all topics, accompanied by organized images.
- Learn from mistakes with detailed answer explanations.
- Easy To understand explanations for all students.
Afraid of the Psychopathopharmacology 1 MSN 671 quiz 3 exam challenge? Win against fear with our tested questions.
Free Psychopathopharmacology 1 MSN 671 quiz 3 Questions
Receptor will stop responding to an agonist:
-
When the agonist stops binding to it
-
When the receptor becomes desensitized
-
When the receptor becomes inactivated
-
A and C
-
A, B, and C
Explanation
Correct Answer:
E. A, B, and C
Explanation:
A receptor can stop responding to an agonist under several conditions. If the agonist no longer binds (A), there is no activation. If the receptor becomes desensitized (B), it remains bound to the agonist but no longer initiates a response. If the receptor becomes inactivated (C), it cannot signal even if the agonist binds. Therefore, all three mechanisms explain loss of receptor responsiveness.
Why Other Options Are Wrong:
A. When the agonist stops binding to it
This is true, but incomplete. Receptors can also stop responding even when the agonist is present due to desensitization or inactivation.
B. When the receptor becomes desensitized
This is true but also incomplete. It does not cover the absence of agonist binding or receptor inactivation.
C. When the receptor becomes inactivated
This is also true but partial. It fails to include agonist removal or desensitization as additional reasons for loss of responsiveness.
D. A and C
This is incorrect because it leaves out desensitization, which is a well-established mechanism for receptors becoming unresponsive despite continued agonist binding.
A 48 year old patient with depression was recently started on 20 mg/day fluoxetine to combat his presenting symptoms of apathy, fatigue, problems concentrating, and hypersomnia. The patient reports that he is feeling much energized and can see improvements in his cognition and attention within a day or two of starting fluoxetine. Which properties of fluoxetine are likely responsible for this positive response?
-
5HT2C antagonism
-
Norepi reuptake inhibition
-
Serotonin reuptake inhibition
Explanation
Correct Answer:
A. 5HT2C antagonism
Explanation:
While fluoxetine is primarily an SSRI (serotonin reuptake inhibitor), its early energizing effects are largely attributed to 5HT2C antagonism. The 5HT2C receptor normally inhibits dopamine and norepinephrine release in the prefrontal cortex. By blocking this receptor, fluoxetine disinhibits dopamine and norepinephrine release, leading to improvements in energy, attention, and cognition within days—much faster than the delayed mood-elevating effects from serotonin reuptake inhibition.
Why Other Options Are Wrong:
B. Norepi reuptake inhibition
This is incorrect because fluoxetine is not a norepinephrine reuptake inhibitor. Other antidepressants (e.g., SNRIs, TCAs) provide this effect, but fluoxetine does not significantly block norepinephrine transporters.
C. Serotonin reuptake inhibition
This is incorrect as the explanation for the rapid energizing effect. While fluoxetine does inhibit serotonin reuptake, those changes take weeks to translate into clinical mood improvement. The patient’s immediate boost in energy and cognition is better explained by 5HT2C antagonism.
For which set of disorders is psychosis considered an associated feature rather than a defining feature for diagnosis?
-
Parkinson's disease, schizophreniform disorder
-
Bipolar mania, Parkinson's disease
-
Delusional disorder, Alzheimer disease
Explanation
Correct Answer:
B. Bipolar mania, Parkinson's disease
Explanation:
In bipolar disorder (mania) and Parkinson’s disease, psychosis can occur but is not required for the diagnosis. In mania, the defining feature is elevated, expansive, or irritable mood with increased energy/activity; psychotic features may appear in severe episodes but are not essential. In Parkinson’s disease, psychosis can emerge as a complication of the illness or treatment (e.g., dopamine agonists), but it is not a core diagnostic feature.
Why Other Options Are Wrong:
A. Parkinson's disease, schizophreniform disorder
This is incorrect because while psychosis is not core to Parkinson’s disease, it is core to schizophreniform disorder, where hallucinations, delusions, or disorganized thinking/behavior are defining diagnostic features.
C. Delusional disorder, Alzheimer disease
This is incorrect because psychosis (delusions) is a defining feature of delusional disorder. In Alzheimer disease, psychosis may appear, but since one of the pair (delusional disorder) makes psychosis defining, the set does not fit.
Ligand-Gated Ion Channel receptor sites include the following:
-
Inside the channel
-
Outside the channel
-
Both inside and outside the channel
-
Ligand-gated ion channels do not have receptor sites
Explanation
Correct Answer:
C: Both inside and outside the channel
Explanation:
Ligand-gated ion channels (LGICs), such as GABA-A, nicotinic acetylcholine, and NMDA receptors, are membrane-spanning proteins with primary ligand-binding sites located extracellularly. These external sites allow neurotransmitters to initiate rapid synaptic signaling. However, many LGICs also possess additional modulatory binding sites located within the ion channel pore (e.g., picrotoxin binding inside the GABA-A channel) or on intracellular regions (e.g., phosphorylation sites, binding sites for intracellular modulators). Thus, LGICs can indeed have receptor sites both outside and inside the channel, making option C the most comprehensive answer.
Why Other Options Are Wrong:
A: Inside the channel
This is incomplete. While some modulators bind within the channel pore, the primary neurotransmitter binding sites are extracellular.
B: Outside the channel
This is partially correct, as neurotransmitters like GABA and acetylcholine bind extracellularly. However, it ignores the important modulatory sites inside or intracellularly.
D: Ligand-gated ion channels do not have receptor sites
This is incorrect because their defining property is the presence of receptor sites that bind ligands to open or modulate the channel.
What is the process by which RNA polymerase creates a complementary mRNA strand from a DNA template called?
-
Splicing
-
Replication
-
Translation
-
Transcription
Explanation
Correct Answer:
D. Transcription
Explanation:
Transcription is the process in which RNA polymerase reads the DNA template strand and synthesizes a complementary mRNA strand. This mRNA carries the genetic code from the nucleus to the ribosomes, where proteins are made. Transcription occurs in three stages: initiation, elongation, and termination.
Why Other Options Are Wrong:
A. Splicing
This is incorrect because splicing occurs after transcription in eukaryotes, where introns are removed and exons joined to form mature mRNA.
B. Replication
This is incorrect because replication refers to the copying of the entire DNA molecule before cell division, not the synthesis of RNA.
C. Translation
This is incorrect because translation is the process where the ribosome reads mRNA and builds a polypeptide (protein), not where RNA is made.
A 35-year-old cigarette smoker would like to quit but is nervous because she typically craves a cigarette approximately every 2 hrs. The craving and withdrawal are due to:
-
Desensitization of nicotinic receptors
-
Resensitization of nicotinic receptors
-
Desensitization of muscarinic receptors
-
Resensitization of muscarinic receptors
Explanation
Correct Answer:
B. Resensitization of nicotinic receptors
Explanation:
Nicotine binds to nicotinic acetylcholine receptors (nAChRs) in the brain, causing receptor activation and dopamine release, which produces reinforcement. After nicotine exposure, nAChRs become desensitized and stop responding despite nicotine being present. Over time (about every 1–2 hours), the receptors resensitize, becoming responsive again. This resensitization drives craving and withdrawal because the brain seeks nicotine to re-activate the now-sensitive receptors, creating the cycle of dependence.
Why Other Options Are Wrong:
A. Desensitization of nicotinic receptors
This is incorrect because desensitization occurs right after smoking, not when cravings emerge. Cravings arise when receptors resensitize.
C. Desensitization of muscarinic receptors
This is incorrect because muscarinic acetylcholine receptors are not the primary target of nicotine in addiction. Nicotine acts on nicotinic receptors, not muscarinic ones.
D. Resensitization of muscarinic receptors
This is incorrect because muscarinic receptors are not central to nicotine craving and withdrawal. The addiction mechanism involves nicotinic receptor cycles, not muscarinic receptor activity.
Which ethnic group is more susceptible to carbamazepine-induced Steven Johnson Syndrome, and why?
-
Han Chinese and HLA-B15:02
-
African American and HLA-B15:02
-
White American and HLA-B15:02
-
Hispanic American and HLA-B15:02
Explanation
Correct Answer:
A. Han Chinese and HLA-B*15:02
Explanation:
Han Chinese and several other Southeast Asian populations have a high prevalence of the HLA-B*15:02 allele, which is strongly associated with carbamazepine-induced Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Because of this genetic risk, guidelines recommend genetic testing for HLA-B*15:02 before prescribing carbamazepine in patients of Han Chinese, Thai, or related ancestry.
Why Other Options Are Wrong:
B. African American and HLA-B*15:02
This is incorrect because HLA-B*15:02 is extremely rare in African Americans, so their risk of carbamazepine-induced SJS/TEN is not significantly elevated.
C. White American and HLA-B*15:02
This is incorrect because the prevalence of HLA-B*15:02 is also very low in White Americans, making this population less vulnerable to carbamazepine-induced SJS/TEN.
D. Hispanic American and HLA-B*15:02
This is incorrect because Hispanic populations also have a very low frequency of HLA-B*15:02, so the genetic risk does not typically apply here.
After being arrested for cocaine possession, a 26-year-old patient with ADHD recently checked himself into a drug rehabilitation facility. Because cocaine blocks the dopamine transporter (albeit it is not itself taken up into the neuron by the transporter), it may be an attempt by the patient to self-medicate for symptoms of ADHD. Thus, cocaine has the same action at the dopamine transporter as:
-
Cocaine has the same actions at the dopamine transporter as amphetamine
-
Cocaine has the same actions at the dopamine transporter as methylphenidate
-
A and B
-
Neither A nor B
Explanation
Correct Answer:
B. Cocaine has the same actions at the dopamine transporter as methylphenidate
Explanation:
Cocaine and methylphenidate both block the dopamine transporter (DAT), preventing dopamine reuptake and increasing extracellular dopamine. Neither drug is transported into the presynaptic neuron via DAT; they act from the extracellular side to inhibit transporter function. This mechanism aligns with the acute “energizing” and attention-enhancing effects some users seek, paralleling therapeutic DAT blockade seen with methylphenidate in ADHD.
Why Other Options Are Wrong:
A. Cocaine has the same actions at the dopamine transporter as amphetamine
Amphetamine is taken up via DAT, enters the neuron, disrupts vesicular storage via VMAT2, and reverses DAT to promote dopamine efflux—distinct from simple blockade.
C. A and B
Incorrect because cocaine’s mechanism matches methylphenidate (blockade), not amphetamine (substrate/reverse transporter).
D. Neither A nor B
Incorrect because cocaine clearly shares DAT-blocking action with methylphenidate.
What is retrograde transmission?
-
Synaptic forward transmission from presynaptic neuron A to a postsynaptic neuron B
-
Synaptic backward transmission from postsynaptic neuron B to presynaptic neuron A
-
Non-synaptic transmission from Neuron A back to Neuron A
-
Non-synaptic transmission from Neuron B to neighboring neuron B1 or B2
Explanation
Correct Answer:
B: Synaptic backward transmission from postsynaptic neuron B to presynaptic neuron A
Explanation:
Retrograde transmission occurs when chemical messengers travel from the postsynaptic neuron back to the presynaptic neuron, reversing the usual direction of synaptic communication. Retrograde messengers include nitric oxide, endocannabinoids, and certain peptides. These signals modulate presynaptic activity, often regulating neurotransmitter release or synaptic plasticity. This process plays a crucial role in feedback mechanisms such as long-term potentiation (LTP) and long-term depression (LTD).
Why Other Options Are Wrong:
A: Synaptic forward transmission from presynaptic neuron A to a postsynaptic neuron B
This is incorrect because it describes the normal, forward direction of synaptic communication, not retrograde signaling.
C: Non-synaptic transmission from Neuron A back to Neuron A
This is incorrect because it describes autocrine signaling, where a cell releases signals that act on itself, not retrograde synaptic signaling.
D: Non-synaptic transmission from Neuron B to neighboring neuron B1 or B2
This is incorrect because it refers to paracrine or volume transmission, not retrograde transmission. Retrograde signaling specifically involves communication from the postsynaptic neuron back to its presynaptic partner.
The PMHNP knows that clinicians should carefully consider a client's smoking status when determining a medication for psychosis.
The CYP1A2 enzyme is known to "speed up" the metabolism of some medications in the presence of smoking, causing medications to be less efficacious. Select all the medications below that are metabolized by the CYP1A2 enzyme and effectiveness is significantly reduced by smoking.
-
Olanzapine
-
Lamotrigine
-
Fluphenazine
-
Benztropine
Explanation
Correct Answer:
A. Olanzapine
Explanation:
Cigarette smoke (polycyclic aromatic hydrocarbons) induces CYP1A2, increasing the clearance of drugs that are CYP1A2 substrates. Olanzapine is primarily metabolized by CYP1A2 (with minor roles for UGT and CYP2D6), so smokers often have lower serum levels and reduced efficacy, frequently requiring higher doses compared with non-smokers. When patients start or stop smoking, olanzapine doses often need adjustment to maintain therapeutic effect and avoid side effects.
Why Other Options Are Wrong:
B. Lamotrigine
Incorrect. Lamotrigine is cleared mainly by UGT1A4 glucuronidation, not CYP1A2. Smoking does not meaningfully reduce lamotrigine effectiveness via CYP induction.
C. Fluphenazine
Incorrect. Fluphenazine is metabolized largely by CYP2D6 (and some CYP3A4). While smoking can have modest effects on various pathways, it’s not a CYP1A2 substrate of clinical concern like olanzapine (or clozapine).
D. Benztropine
Incorrect. Benztropine is not primarily metabolized by CYP1A2, and smoking is not known to significantly reduce its effectiveness through this mechanism.
How to Order
Select Your Exam
Click on your desired exam to open its dedicated page with resources like practice questions, flashcards, and study guides.Choose what to focus on, Your selected exam is saved for quick access Once you log in.
Subscribe
Hit the Subscribe button on the platform. With your subscription, you will enjoy unlimited access to all practice questions and resources for a full 1-month period. After the month has elapsed, you can choose to resubscribe to continue benefiting from our comprehensive exam preparation tools and resources.
Pay and unlock the practice Questions
Once your payment is processed, you’ll immediately unlock access to all practice questions tailored to your selected exam for 1 month .